292 related articles for article (PubMed ID: 29048609)
1. Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS; Apostolatos AH; Ostrov DA; Acevedo-Duncan M
Int J Oncol; 2017 Nov; 51(5):1370-1382. PubMed ID: 29048609
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors.
Ratnayake WS; Apostolatos CA; Apostolatos AH; Schutte RJ; Huynh MA; Ostrov DA; Acevedo-Duncan M
Cell Adh Migr; 2018; 12(5):447-463. PubMed ID: 29781749
[TBL] [Abstract][Full Text] [Related]
3. Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway.
BommaReddy RR; Patel R; Smalley T; Acevedo-Duncan M
Onco Targets Ther; 2020; 13():1661-1676. PubMed ID: 32158232
[TBL] [Abstract][Full Text] [Related]
4. A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma.
Pillai P; Desai S; Patel R; Sajan M; Farese R; Ostrov D; Acevedo-Duncan M
Int J Biochem Cell Biol; 2011 May; 43(5):784-94. PubMed ID: 21315177
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
Yang Y; Liu Y; He JC; Wang JM; Schemmer P; Ma CQ; Qian YW; Yao W; Zhang J; Qi WP; Fu Y; Feng W; Yang T
Oncotarget; 2016 Aug; 7(34):55191-55210. PubMed ID: 27409422
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase C-ζ stimulates colorectal cancer cell carcinogenesis via PKC-ζ/Rac1/Pak1/β-Catenin signaling cascade.
Islam SMA; Patel R; Acevedo-Duncan M
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):650-664. PubMed ID: 29408512
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade.
Apostolatos AH; Ratnayake WS; Win-Piazza H; Apostolatos CA; Smalley T; Kang L; Salup R; Hill R; Acevedo-Duncan M
Int J Oncol; 2018 Nov; 53(5):1836-1846. PubMed ID: 30226591
[TBL] [Abstract][Full Text] [Related]
8. PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.
Desai S; Pillai P; Win-Piazza H; Acevedo-Duncan M
Biochim Biophys Acta; 2011 Jun; 1813(6):1190-7. PubMed ID: 21419810
[TBL] [Abstract][Full Text] [Related]
9. Knockdown on aPKC-ι inhibits epithelial-mesenchymal transition, migration and invasion of colorectal cancer cells through Rac1-JNK pathway.
Du GS; Qiu Y; Wang WS; Peng K; Zhang ZC; Li XS; Xiao WD; Yang H
Exp Mol Pathol; 2019 Apr; 107():57-67. PubMed ID: 30465755
[TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of atypical PKC signaling and PI3K/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell Renal Cell Carcinoma.
Khalid KM; Ratnayake WS; Apostolatos CA; Acevedo-Duncan M
Front Oncol; 2023; 13():1213715. PubMed ID: 38288105
[TBL] [Abstract][Full Text] [Related]
11. aPKC-ι/P-Sp1/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma.
Qian Y; Yao W; Yang T; Yang Y; Liu Y; Shen Q; Zhang J; Qi W; Wang J
Hepatology; 2017 Oct; 66(4):1165-1182. PubMed ID: 28574228
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.
Wu X; Li J; Zhu M; Fletcher JA; Hodi FS
Mol Cancer Ther; 2012 Sep; 11(9):1905-14. PubMed ID: 22653968
[TBL] [Abstract][Full Text] [Related]
13. Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion.
Ratnayake WS; Apostolatos CA; Breedy S; Dennison CL; Hill R; Acevedo-Duncan M
Cell Adh Migr; 2021 Dec; 15(1):37-57. PubMed ID: 33525953
[TBL] [Abstract][Full Text] [Related]
14. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway.
Tian L; Deng Z; Xu L; Yang T; Yao W; Ji L; Lu Y; Zhang J; Liu Y; Wang J
Cell Death Dis; 2018 Nov; 9(11):1115. PubMed ID: 30389910
[TBL] [Abstract][Full Text] [Related]
16. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma.
Du GS; Wang JM; Lu JX; Li Q; Ma CQ; Du JT; Zou SQ
Ann Surg Oncol; 2009 Jun; 16(6):1578-86. PubMed ID: 19290490
[TBL] [Abstract][Full Text] [Related]
17. Expression of the atypical protein kinase C (aPKC) isoforms iota/lambda and zeta during mouse embryogenesis.
Kovac J; Oster H; Leitges M
Gene Expr Patterns; 2007 Jan; 7(1-2):187-96. PubMed ID: 16931174
[TBL] [Abstract][Full Text] [Related]
18. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
Lu Y; Jamieson L; Brasier AR; Fields AP
Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression.
Breedy S; Ratnayake WS; Lajmi L; Hill R; Acevedo-Duncan M
Front Oncol; 2023; 13():1051516. PubMed ID: 36776326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]